Home

Mech Kaligrafie úsilí acs med chem lett Léčivý Relaxační nikl

Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy | ACS Medicinal Chemistry Letters
Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy | ACS Medicinal Chemistry Letters

Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors | ACS Medicinal Chemistry Letters
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors | ACS Medicinal Chemistry Letters

Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design | ACS Medicinal Chemistry Letters
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design | ACS Medicinal Chemistry Letters

Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules | ACS Medicinal Chemistry Letters
Systematic Study of Effects of Structural Modifications on the Aqueous Solubility of Drug-like Molecules | ACS Medicinal Chemistry Letters

Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4 | ACS Medicinal Chemistry Letters
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4 | ACS Medicinal Chemistry Letters

Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833 | ACS Medicinal Chemistry Letters
Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833 | ACS Medicinal Chemistry Letters

Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery | ACS Medicinal Chemistry Letters
Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery | ACS Medicinal Chemistry Letters

Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35 | ACS Medicinal Chemistry Letters
Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35 | ACS Medicinal Chemistry Letters

Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448) | ACS Medicinal Chemistry Letters
Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448) | ACS Medicinal Chemistry Letters

Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs | ACS Medicinal Chemistry Letters
Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs | ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters | Vol 11, No 11
ACS Medicinal Chemistry Letters | Vol 11, No 11

Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion | ACS Medicinal Chemistry Letters
Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion | ACS Medicinal Chemistry Letters

Readily Accessible High-Throughput Experimentation: A General Protocol for the Preparation of ChemBeads and EnzyBeads | ACS Medicinal Chemistry Letters
Readily Accessible High-Throughput Experimentation: A General Protocol for the Preparation of ChemBeads and EnzyBeads | ACS Medicinal Chemistry Letters

Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists | ACS Medicinal Chemistry Letters
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists | ACS Medicinal Chemistry Letters

Evaluation of 3-Dimensionality in Approved and Experimental Drug Space | ACS Medicinal Chemistry Letters
Evaluation of 3-Dimensionality in Approved and Experimental Drug Space | ACS Medicinal Chemistry Letters

Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters
Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters

Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters
Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents | ACS Medicinal Chemistry Letters

Author Guidelines
Author Guidelines

Discovery and Development of Cyclic Peptide Inhibitors of CIB1 | ACS Medicinal Chemistry Letters
Discovery and Development of Cyclic Peptide Inhibitors of CIB1 | ACS Medicinal Chemistry Letters

An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters | ACS Medicinal Chemistry Letters
An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters | ACS Medicinal Chemistry Letters

GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters | Ahead of Print
ACS Medicinal Chemistry Letters | Ahead of Print

Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors | ACS Medicinal Chemistry Letters
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors | ACS Medicinal Chemistry Letters

Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors | ACS Medicinal Chemistry Letters
Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors | ACS Medicinal Chemistry Letters

Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series | ACS Medicinal Chemistry Letters
Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series | ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters: Volume 11, Issue 5
ACS Medicinal Chemistry Letters: Volume 11, Issue 5